Previous Close | 12.10 |
Open | 12.39 |
Bid | 11.00 x 100 |
Ask | 14.75 x 1200 |
Day's Range | 11.82 - 13.31 |
52 Week Range | 9.00 - 24.20 |
Volume | |
Avg. Volume | 3,749 |
Market Cap | 16.409M |
Beta (5Y Monthly) | 1.42 |
PE Ratio (TTM) | 5.06 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Acorda Therapeutics, Inc. ( NASDAQ:ACOR ) shareholders are no doubt pleased to see that the share price has bounced 53...
Acorda Therapeutics, Inc. (NASDAQ:ACOR) Q3 2023 Earnings Call Transcript November 13, 2023 Operator: Welcome to Acorda Therapeutics Third Quarter 2023 Financial and Business Update. At this time, all participants are in a listen-only mode. There will be a question-and-answer session to follow. Please be advised that this call is being recorded at the company’s request. […]
Acorda Therapeutics, Inc.'s ( NASDAQ:ACOR ) price-to-sales (or "P/S") ratio of 2.1x might make it look like a strong...